Neumora Therapeutics, Inc.
NMRA
$1.28
-$0.12-8.57%
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 307.58M | 341.31M | 371.64M | 422.72M | 453.98M |
| Total Receivables | -- | -- | 1.63M | 906.00K | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 5.26M | 6.09M | 3.83M | 4.56M | 18.00M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | 1.21M | 1.21M | 21.22M | 14.60M | 6.30M |
| Total Current Assets | 314.06M | 348.61M | 398.32M | 442.79M | 478.28M |
|
|
|||||
| Total Current Assets | 314.06M | 348.61M | 398.32M | 442.79M | 478.28M |
| Net Property, Plant & Equipment | 2.92M | 3.93M | 4.94M | 5.91M | 6.86M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -- | -- | 1.21M | 1.21M | 1.21M |
| Total Assets | 316.97M | 352.54M | 404.47M | 450.21M | 496.20M |
|
|
|||||
| Total Accounts Payable | 3.31M | 6.11M | 1.08M | 1.49M | 337.00K |
| Total Accrued Expenses | 24.59M | 22.76M | 18.30M | 19.49M | 21.26M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 1.85M | 2.75M | 3.61M | 3.49M | 3.38M |
| Total Finance Division Other Current Liabilities | 133.00K | 133.00K | 133.00K | 133.00K | 139.00K |
| Total Other Current Liabilities | 133.00K | 133.00K | 133.00K | 133.00K | 139.00K |
| Total Current Liabilities | 29.89M | 31.74M | 23.13M | 24.61M | 25.11M |
|
|
|||||
| Total Current Liabilities | 29.89M | 31.74M | 23.13M | 24.61M | 25.11M |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | 938.00K | 1.85M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 22.00K | 55.00K | 89.00K | 122.00K | 155.00K |
| Total Liabilities | 29.91M | 31.80M | 23.21M | 25.67M | 27.12M |
|
|
|||||
| Common Stock & APIC | 1.23B | 1.21B | 1.20B | 1.18B | 1.17B |
| Retained Earnings | -947.22M | -888.40M | -815.86M | -757.16M | -703.43M |
| Treasury Stock & Other | 62.00K | 105.00K | -187.00K | -148.00K | -76.00K |
| Total Common Equity | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 287.06M | 320.74M | 381.26M | 424.54M | 469.08M |
|
|
|||||
